SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoins sharp rally and breakout are drawing attention, with bullish traders pointing to unusual strength, rising volume, and a possible short squeeze while comparing its move to Zcashs run. Skeptics question whether the gains can hold, citing Litecoins history of fading rallies; ETF, LitVM, and halving themes also appear as speculative longer-term narratives.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is drawing attention amid a broad crypto rally, with traders highlighting its relative strength and debating whether the move can sustain a breakout or faces a pullback. Bullish discussion also points to tokenization and network activity, while skeptics cite technical resistance and broader crypto-market weakness.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak announced that it will report Phase 3 DAYBREAK topline results for its wet AMD candidates, Zenkuda and KSI-501, on September 28. Traders are positioning around the binary readout, with optimism about potential results competing with concerns about trial risk, profit-taking, and volatile price action.

Akamai Technologies, Inc. is the cybersecurity and cloud computing company that powers and protects business online. The market security solutions, superior threat intelligence, and global operations team provide defense in depth to safeguard enterprise data and applications everywhere. The firm full-stack cloud computing solutions deliver performance and affordability on the world’s most distributed platform. The global enterprises trust Akamai to provide the industry reliability, scale, and expertise they need to grow their business with confidence. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamais expanded multiyear cloud-computing agreement with Anthropic is drawing attention as traders weigh its potential to accelerate the companys AI infrastructure business. Optimism about the deals scale is tempered by concerns over substantial upfront investment, possible dilution, and the stocks sharp fade after its initial jump.

Vistra Corp. is a holding company, which engages in the provision of electricity and power generation. It operates through the following segments: Retail, Texas, East, West, and Asset Closure. The Retail segment includes sale of electricity and natural gas to residential, commercial, and industrial customers. The Texas and East segments are involved in electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production and fuel logistics management. The West segment represents the company's electricity generation operations in CAISO. The Asset Closure segment refers to the decommissioning and reclamation of retired plants and mines. The company was founded in 1882 and is headquartered in Irving, TX.

Vistra Corp

Vistras persistent weakness and choppy trading are drawing attention, with traders debating whether financing filings signal dilution or simply give the company funding flexibility. Bulls continue to cite its potential role in powering AI data centers and see the pullback as a buying opportunity, while bears focus on selling pressure and the lack of a sustained rebound.

Sui s a Layer 1 blockchain developed by Mysten Labs, a team founded by former lead engineers from Meta’s blockchain research division. It is designed for global adoption by providing a secure, high-speed environment for digital asset ownership and removing technical barriers for Web3 applications. The platform utilizes the Move programming language to create a safe framework and supports horizontal scaling to keep fees stable and speeds high as the network grows. Significant institutional support comes from major venture capital firms including Andreessen Horowitz, Coinbase Ventures, Circle Ventures, and YZi Labs.  The system functions by organizing data into independent objects rather than a single ledger of accounts. This object-centric data model enables parallel execution, allowing the network to process many transactions simultaneously instead of waiting for one to finish before starting the next. This architecture is built for rapid transaction finalization to ensure near-instant results. To maintain long-term stability, the network collects fees into a storage fund that rewards validators for keeping data on the network indefinitely.  Sui offers several advanced tools including zkLogin for easier account access and sponsored transactions that allow users to interact with apps without managing complex wallets or immediate fees. Developers can also create tailored object types that work across the entire network, which encourages innovation and deep composability. These features are designed to create a more user-friendly experience for interacting with decentralized applications and digital games.  The SUI token is central to the ecosystem, serving as the primary asset for transaction fees and on-chain utility within decentralized exchanges and lending platforms. Users participate in a proof-of-stake mechanism by locking their tokens to support validators and secure the blockchain in exchange for rewards. Additionally, token holders have a role in governance, allowing them to participate in voting on network rules and future protocol upgrades. Value moves through the system through these staking rewards and transaction fees to ensure the platform scales sustainably

SUIs sharp rebound has traders focused on a possible technical breakout, with many cheering the move and anticipating further gains as altcoins catch bids alongside Bitcoin. Others remain cautious about whether the rally can hold, citing SUIs past volatility and network reliability concerns.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Attention centers on Sareptas anticipated SRP-1003 DM1 and SRP-1001 FSHD data, with Novartis/Aviditys HARBOR trial failure raising concern that DMPK knockdown may not translate into functional benefit. Traders debate how much that result applies to Sareptas different delivery approach and view the companys own readouts as crucial; their timing remains uncertain.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

CVS is drawing attention for a rebound after a string of declines, with traders pointing to strong second-quarter results and raised full-year guidance as support. Some see the move as an oversold technical bounce, while others remain cautious after the stocks recent weakness.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

HSBCs downgrade to Reduce is weighing on Twilio after its AI-agent-related rally, with the analyst questioning how much of the added communications traffic Twilio can capture if Meta keeps valuable voice functions within its own stack. Bulls counter that AI agents could still lift calls, texts, and authentication volumes across communications platforms, leaving traders divided over growth potential versus competitive and margin risks.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riots shift from Bitcoin mining toward AI/HPC data centers is the dominant focus, particularly its announced long-term Rockdale lease and AMD-related capacity; traders also speculate about a larger Corsicana tenant deal, which remains unconfirmed. The community is divided: bulls see potential for a business re-rating, while frustrated holders question the weak share performance despite Bitcoin strength and debate dilution and execution risks.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week

Co-Diagnostics to Participate in Global Health Events During UN General Assembly Week Co-Diagnostics to Participate in Global Health Events During UN General Assembly WeekPR NewswireSALT LAKE CITY, Sept. 23, 2026 Events Bring Together Global Health Leaders to Examine Tuberculosis and Preparedness...

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation

Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak Innovation Co-Diagnostics to Participate in Global Health Roundtable on Ebola and Outbreak InnovationPR NewswireSALT LAKE CITY, Sept. 21, 2026Roundtable discussion, taking place in New York City, will examine the...

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026

Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026 Co-Diagnostics to Participate in Joint WHO/Unitaid/UNAIDS Annual Consultation Meeting on September 17-18, 2026PR NewswireSALT LAKE CITY, Sept. 17, 2026 SALT LAKE CITY, Sept. 17, 2026...

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with EbolaPR NewswireSALT LAKE CITY, Sept. 16, 2026 Blood-based...

Co-Diagnostics to Hold Press Conference

Co-Diagnostics to Hold Press Conference Co-Diagnostics to Hold Press ConferencePR NewswireSALT LAKE CITY, Sept. 15, 2026 Media, analysts and investors are welcome to attend in person or via live webcast, Sept. 16 at 10:30 a.m. ETSALT LAKE CITY, Sept. 15, 2026 /PRNewswire/ -- Co-Diagnostics...

Co-Diagnostics Completes New Vector Smart Laboratory Installations Amid Rising Dengue Activity in Florida

Co-Diagnostics Completes New Vector Smart Laboratory Installations Amid Rising Dengue Activity in Florida Co-Diagnostics Completes New Vector Smart Laboratory Installations Amid Rising Dengue Activity in Florida PR Newswire SALT LAKE CITY, Sept. 10, 2026 Two full laboratory installations completed...

United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday

Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey's earnings expected.read more...

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India

Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India Co-Diagnostics Launches Integrated Cloud and Mobile Infrastructure in India PR Newswire SALT LAKE CITY, Sept. 3, 2026 Localized cloud environment is designed to support ongoing clinical studies and establish the digital...

Co-Diagnostics Expands Vector Smart Customer Reach with First International Installation in USAF Base

Co-Diagnostics Expands Vector Smart Customer Reach with First International Installation in USAF Base Co-Diagnostics Expands Vector Smart Customer Reach with First International Installation in USAF Base PR Newswire SALT LAKE CITY, Sept. 1, 2026 Shipments of laboratory equipment and other mosquito...

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event

Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event Co-Diagnostics Participates in Medical Devices and Innovations Roundtable Media Event PR Newswire SALT LAKE CITY, Aug. 18, 2026 Company Chief Commercialization Officer represented Co-Dx in an event featuring other...

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.

Co-Diagnostics Inc

S&P 500, Nasdaq Close At Record Highs Amid Hopes Of Diplomatic Resolution Between US And Iran — MU, QCOM, LUNR, LLY, CODX In Focus

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

CODX Co-Diagnostics Inc